Background: Floating drug delivery systems have been reported for different active pharmaceutical ingredients as single-unit tablets with gas-generating agents. In this present research, the formulation of floating multiple-unit minitablets of Nimodipine without using gas-generating agent was attempted with an objective of increased residence time, sustain-release and improved oral bioavailability. Solid dispersion with different ratios (1:0.5, 1:1, 1:1.5, 1:2, 1:2.5) of drug with the lipophilic carrier such as Compritol ATO 888, Gelucire 43/01, G39/01 and Precirol ATO 05 was formulated using melt granulation technique. The adsorbent Sylysia 350 to lipophilic carrier is maintained at 1:1. The granules were compressed into minitablets weighing 15 mg and were filled into a ‘0’ size capsule. Results: Differential scanning calorimetry study justified no interaction of the drug with excipients. The formulations which exhibited desirable flow property, floating lag time less than 1 min and floating time of 12 h were further characterized for various post-compression parameters. The optimized single-dose (capsule) of floating multiple-unit minitablets of Nimodipine consisting of 60 mg of drug, 120 mg of G43/01 and 120 mg of Sylysia 350 showed an average of floating lag time within 24.48 s, floating time of 14.32 h and sustained-release up to 12 h. Pharmacokinetic study of the optimized formulation (F9) showed nearly 2.5 times increase in area under the curve with increased residence time in comparison to aqueous suspension of Nimodipine. The stability study revealed no significant change in various parameters before and after storage. Conclusion: Hence, gelucire 43/01-based multiple-unit minitablets of Nimodipine can be considered a promising approach for sustaining the drug release with gastric retention for 12 h without using gas-generating agent.
Background: Health is a lively state of the body which adjusts and adopt with the response to various environmental changes. There are several features that can influence the health status of human beings. Therefore, the continuous research study is highly essential to maintain a proper health care system in the community. Objective: The diverse area of innovation was made in nanotechnology for diagnosis and treatment of life-threatening diseases, such as obesity, diabetes, cardiovascular disorders, cancer, leukemia, neurodegenerative disorders like Alzheimer's disease and Parkinson's diseases, etc. Nanotechnology generally refers to the materials, devices, and systems in nanoscale which provides considerably improved physical, chemical and biological property. Methods: It is technology which deals with the design, synthesis, characterization of substances, devices and systems by arranging shape and size at their nanometer scale. It involves multidisciplinary research which includes both health science and technology for the treatment of human health. Nanotechnology can be applied at the cellular level in the human body with a high degree of specificity to treat the various diseases. Conclusion: This technology is potentially targeted to diseased tissue to achieve maximum therapeutic efficacy with fewer side effects. Nowadays, the rapidity of revolutionary discoveries in the field of nanotechnology is expected to accelerate in the next decade globally.